Whitebox Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Whitebox Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-199,740	Closed	-$9.06M	–	101
2019 Q2	$9.06M	Buy	+199,740	New	+$9.3M	0.32%	46
2016 Q1	–	Sell	-27,579	Closed	-$1.9M	–	96
2015 Q4	$1.9M	Sell	27,579 -33,526	-55%	-$2.22M	0.05%	126
2015 Q3	$3.62M	Buy	61,105 +1,160	+2%	+$73.6K	0.16%	126
2015 Q2	$3.99M	Buy	59,945 +4,140	+7%	+$273K	0.17%	130
2015 Q1	$3.6M	Buy	+55,805	New	+$3.49M	0.14%	140
2014 Q3	–	Sell	-6,200	Closed	-$301K	–	396
2014 Q2	$301K	Buy	+6,200	New	+$306K	0.01%	361

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Whitebox Advisors's BMY Position: Q3 2019 in Review

Whitebox Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 199,740 shares — an estimated $9.06M sold.

Whitebox Advisors first reported a position in BMY in Q2 2014 and held it in 6 quarters. The position peaked at $9.06M in Q2 2019. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Whitebox Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
Whitebox Advisors sold 199,740 Bristol-Myers Squibb shares in Q3 2019, an estimated $9.06M.
Whitebox Advisors first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 6 quarters.
Whitebox Advisors's Bristol-Myers Squibb position peaked at $9.06M in Q2 2019.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Whitebox Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.